E Fund Management Co., Ltd. Tg Therapeutics, Inc. Transaction History

E Fund Management Co., Ltd.

$2.07 Billion
Q1 2025

A detailed history of E Fund Management Co., Ltd. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 16,996 shares of TGTX stock, worth $460,931. This represents 0.03% of its overall portfolio holdings.

Number of Shares

16,996

Previous 23,554 27.84%

Holding current value

$460,931

Previous $708,000 5.37%

% of portfolio

0.03%

Previous 0.04%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$27.67 - $42.99 $181,459 - $281,928	-6,558 Reduced 27.84%	16,996 $670,000
Q4 2024 Feb 06, 2025	BUY	$21.31 - $35.09 $36,461 - $60,038	1,711 Added 7.83%	23,554 $708,000
Q3 2024 Nov 12, 2024	BUY	$17.21 - $25.28 $23,715 - $34,835	1,378 Added 6.73%	21,843 $510,000
Q2 2024 Aug 12, 2024	SELL	$13.32 - $19.19 $71,408 - $102,877	-5,361 Reduced 20.76%	20,465 $364,000
Q1 2024 May 13, 2024	SELL	$13.02 - $21.3 $61,545 - $100,685	-4,727 Reduced 15.47%	25,826 $392,000
Q4 2023 Feb 06, 2024	SELL	$6.68 - $18.81 $89,892 - $253,126	-13,457 Reduced 30.58%	30,553 $521,000
Q3 2023 Nov 13, 2023	BUY	$8.36 - $26.5 $231,939 - $735,216	27,744 Added 170.56%	44,010 $368,000
Q2 2023 Aug 11, 2023	SELL	$15.48 - $35.0 $172,787 - $390,670	-11,162 Reduced 40.7%	16,266 $404,000
Q1 2023 May 11, 2023	SELL	$10.23 - $19.34 $122,401 - $231,403	-11,965 Reduced 30.37%	27,428 $413,000
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $68,922 - $162,745	-13,757 Reduced 25.88%	39,393 $466,000
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $77,484 - $142,422	-16,955 Reduced 24.19%	53,150 $315,000
Q2 2022 Aug 15, 2022	BUY	$3.74 - $10.66 $148,186 - $422,370	39,622 Added 129.98%	70,105 $298,000
Q1 2022 May 12, 2022	BUY	$7.81 - $20.45 $156,332 - $409,347	20,017 Added 191.26%	30,483 $290,000
Q4 2021 Feb 11, 2022	BUY	$15.2 - $35.51 $116,796 - $272,858	7,684 Added 276.2%	10,466 $199,000
Q1 2021 May 12, 2021	BUY	$41.61 - $54.3 $115,759 - $151,062	2,782 New	2,782 $134,000

Others Institutions Holding TGTX

# of Institutions

414

Shares Held

89.3M

Call Options Held

2.34M

Put Options Held

1.93M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $3.94B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Tg Therapeutics, Inc. Transaction History